Karajannis, Matthias A <br/><br/>
Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas.  [electronic resource] 

 -  Neuro-oncology  Sep 2012 
 - 1163-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1523-5866 
<br/><br/><label>Standard No.: </label>10.1093/neuonc/nos146  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Agents--pharmacokinetics<br/>Child<br/>Child, Preschool<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lapatinib<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Neurofibromatosis 2--complications<br/>Neuroma, Acoustic--complications<br/>Prognosis<br/>Prospective Studies<br/>Quinazolines--pharmacokinetics<br/>Survival Rate<br/>Tissue Distribution<br/>Young Adult